Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
December 10, 2024
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
Read More
Contact Us
Privacy Policy
Menu
RAP Platform™
RNA Actuators
·
Programmable Therapeutics
·
Publications & Presentations
·
January 25, 2024
Scientific Reports
Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration
December 14, 2023
Keystone Symposia Regulatory RNAs: Emerging Mechanisms
Antisense oligonucleotide therapeutic candidates targeting regulatory RNAs to treat urea cycle disorders
December 6, 2023
Nucleic Acids Research
JMnorm: a novel joint multi-feature normalization method for integrative and comparative epigenomics
October 18, 2023
Nature Conferences Cracking the Code: The Dawn of Nucleic Acid Medicines
Enhancer identification using machine learning enables efficient enhancer RNA targeting with antisense oligonucleotide-based therapeutics
October 18, 2023
Nature Conferences Cracking the Code: The Dawn of Nucleic Acid Medicines
Antisense oligonucleotide therapeutic candidates targeting regulatory RNAs to treat urea cycle disorders
August 6, 2023
Chromatin and Regulation of Gene Expression, Penn State’s 39th Summer Symposium in Molecular Biology
JMnorm: a novel Joint Multi-feature normalization method for integrative and comparative epigenomics
May 7, 2023
TIDES USA Oligonucleotide & Peptide Therapeutics conference
Antisense oligo targeting of GRN regulatory RNA upregulates progranulin: a potential therapeutic approach for granulin-related frontotemporal dementia
March 14, 2023
Cold Spring Harbor Network Biology meeting
JMnorm: a novel method for Joint Multi-feature normalization of epigenomic data
November 7, 2022
AASLD The Liver Meeting 2022
Upregulation of a bile acid regulator by targeting regulatory RNAs can enhance hepatic bile acid efflux in PBC
October 26, 2022
ASHG 2022 Annual Meeting
Linking GWAS risk variants to disease genes by epigenomic mapping and prediction of functional enhancer-promoter interactions
October 2, 2022
18TH ANNUAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
Targeting regRNAs with oligonucleotides to treat OTC deficiency
October 2, 2022
18TH ANNUAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
Upregulation of SerpinG1 for treatment of hereditary angioedema using RNA actuators
April 25, 2022
DIA/FDA Oligonucleotide-Based Therapeutics Conference
Upregulation of SCN1A by regRNA-Targeting Antisense Oligonucleotide CMP-SCN
March 11, 2022
Cold Spring Harbor Laboratory 15th Annual Global Regulation of Gene Expression Conference
Accurate Prediction of Functional Enhancer-Promoter Interactions Using Epigenomic Data
December 3, 2021
American Epilepsy Society Annual Meeting
SCN1A Upregulation via Antisense Oligonucleotides Targeting SCN1A-NAT as a Novel Therapeutic Strategy for Dravet Syndrome
November 18, 2021
30th Annual Irwin Arias symposium
A Novel Treatment Approach For Treating OTC Deficiency By Targeting RegRNAs Using Oligonucleotides
September 26, 2021
17TH ANNUAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
A Novel Treatment Approach For Treating OTC Deficiency By Targeting RegRNAs Using Oligonucleotides
September 26, 2021
17th Annual Meeting of the Oligonucleotide Therapeutics Society
Oligonucleotide Upregulation of Serping1 by Targeting Regulatory RNAs
Top
